University of campinas - Latest News Update, Information, Photos & Videos on University of campinas at Lokmat Times

Beijing, July 9 Two doses of China's CoronaVac vaccine offer 83.5 per cent protection against symptomatic Covid-19 disease, but antibodies generated by the jab work less well against the Gamma (P1) variant, according to two separate studies published in the science journal the Lancet.The first study, led by researchers from the University of Campinas in Brazil and published in The Lancet Microbe, showed that antibodies from almost all of the people who were both partially and fully vaccinated with CoronaVac had no detectable effect on the P1 variant.In contrast, the P1 variant was still sensitive to the antibodies in the plasma of those who had two doses in the immunisation programme (second dose 17-38 days earlier) but to a lesser extent than the B lineage virus.The P1 variant was discovered in Manaus, Brazil, in early January 2021 and has 15 unique mutations.Previous studies have found evidence that it can escape neutralisation by antibodies."Neutralising antibodies are an important component of the immune response against SARS-CoV-2. Therefore, the capacity of the P1 variant to evade antibodies present in the plasma of CoronaVac-immunised individuals suggests that the virus can potentially circulate in vaccinated individuals even in areas with high vaccination rates," said Jose Luiz Proenca-Modena, from the varsity's Laboratory of Emerging Viruses.However, interim data from a phase 3 trial published in The Lancet showed that two doses of China's CoronaVac vaccine offer 83.5 per cent protection against symptomatic Covid-19 disease, and can protect against severe disease and death."Therefore, neutralising antibodies might not be the only contributing factor the T-cell response may also play an important role in reducing disease severity," Proenca-Modena said.The phase 3 trial led by researchers from the Hacettepe University Medical School in Ankara, Turkey, indicates that CoronaVac induces a robust antibody response among 90 per cent of those who received the vaccine.But, the antibody response decreased with increasing age in men and women.CoronaVac uses an inactivated whole virus. The vaccine induces the immune system to attack the harmless form of the virus by producing antibodies to fight it off, leading to immunity.Developed by Sinovac Life Sciences, the vaccine, which can be stored and transported at 2-8 degrees Celsius, has been approved for emergency use in 22 countries."One of the advantages of CoronaVac is that it does not need to be frozen, making it easier to transport and distribute. This could be particularly important for global distribution, as some countries may struggle to store large amounts of vaccine at very low temperatures," said lead author Professor Murat Akova, from Hacettepe.No severe adverse events or deaths were reported among the more than 10,000 trial participants in Turkey, with most adverse events mild and occurring within seven days of an injection.However, more research is needed to confirm vaccine efficacy in the long term, in a more diverse group of participants, and against emerging variants of concern, the team said.The studies will also be presented at the 2021 European Congress of Clinical Microbiology and Infectious Diseases to be held online between July 9 and 12.Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Trump Tarrifs

Tahawwur Rana

IPL 2025

CM Devendra Fadnavis

Mumbai Local

Weather Update

University Of Campinas, NewsFOLLOW

University of campinas, Latest News

Health :Early stages of Parkinson's disease can be traced through sensor: Study

Sau Paulo [Brazil], April 15 : Researchers at the Federal University of So Carlos (UFSCar) and the University of ... ...

Technology :Study reveals how low-cost sensor detects early-stage of Parkinson's disease

Sau Paulo [Brazil], April 13 : An electrochemical sensor that can identify Parkinson's disease at various stages has been ... ...

Technology :Study finds gravitational action of sun, moon influence animals, plants

A team of international researchers has shed light on the fact that the rhythms of activity in all biological organisms, both plants, and animals, are closely linked to the gravitational tides created by orbital mechanics of the Sun-Earth-Moon system ...

Technology :Gravitational action of sun and moon influences behaviour of animals and plants, study shows

The rhythms of activity in all biological organisms, both plants and animals, are closely linked to the gravitational tides created by the orbital mechanics of the Sun-Earth-Moon system. This truth has been somewhat neglected by scientific research b ...

Health :CoronaVac jabs less effective against Gamma variant: Lancet

Beijing, July 9 Two doses of China's CoronaVac vaccine offer 83.5 per cent protection against symptomatic Covid-19 disease, ... ...